Maitreya Medicare (NSE:MAITREYA) EBIT: ₹39.3 Mil (TTM As of Sep. 2023)


NSE:MAITREYA Maitreya Medicare Ltd NSE:MAITREYA
18 GF Score
Price ₹137.85
View Full Analysis

What is Maitreya Medicare EBIT?

Maitreya Medicare NSE:MAITREYA -0.11% 18 EBIT is ₹39.3 Mil as of Sep. 2023. GuruFocus rates NSE:MAITREYA with a GF Score™ of 18/100.

Maitreya Medicare's earnings before interest and taxes (EBIT) for the six months ended in Sep. 2023 was ₹39.3 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2023 was ₹39.3 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Maitreya Medicare's annualized ROC % for the quarter that ended in Sep. 2023 was 33.14%. Maitreya Medicare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was 41.98%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Maitreya Medicare's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was 2.52%.

Maitreya Medicare  (NSE:MAITREYA) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Maitreya Medicare's annualized ROC % for the quarter that ended in Sep. 2023 is calculated as:

ROC % (Q: Sep. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2023 ) + Invested Capital (Q: Sep. 2023 ))/ count )
=101.092 * ( 1 - 29.72% )/( (199.968 + 228.743)/ 2 )
=71.0474576/214.3555
=33.14 %

where

Invested Capital(Q: Mar. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=274.989 - 53.337 - ( 21.684 - max(0, 68.428 - 137.036+21.684))
=199.968

Invested Capital(Q: Sep. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=312.231 - 66.654 - ( 16.834 - max(0, 87.038 - 180.389+16.834))
=228.743

Note: The Operating Income data used here is two times the semi-annual (Sep. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Maitreya Medicare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2023  Q: Sep. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=78.58/( ( (115.756 + max(59.63, 0)) + (109.829 + max(89.12, 0)) )/ 2 )
=78.58/( ( 175.386 + 198.949 )/ 2 )
=78.58/187.1675
=41.98 %

where Working Capital is:

Working Capital(Q: Mar. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(97.341 + 7.985 + 9.865) - (53.337 + 0 + 2.224)
=59.63

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(150.39 + 5.091 + 7.816) - (66.654 + 0 + 7.523)
=89.12

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Sep. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Maitreya Medicare's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2023 )
=39.29/1556.108
=2.52 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maitreya Medicare EBIT Related Terms

Maitreya Medicare EBIT Historical Data

* Premium members only.

The historical data trend for Maitreya Medicare's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maitreya Medicare EBIT Chart

Maitreya Medicare Annual Data
Trend Mar21 Mar22 Mar23
EBIT
64.05 22.01 64.72

Maitreya Medicare Semi-Annual Data
Mar21 Mar22 Mar23 Sep23
EBIT 0.00 0.00 0.00 39.29

NSE:MAITREYA vs HCA, DVA, THC: EBIT Comparison

For the Medical Care Facilities subindustry, Maitreya Medicare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Maitreya Medicare EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Maitreya Medicare's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Maitreya Medicare's EV-to-EBIT falls into.


NSE:MAITREYA
18GF Score
Maitreya Medicare Ltd NSE:MAITREYA
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Maitreya Medicare EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹39.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹39.3 Mil mean?
Maitreya Medicare (NSE:MAITREYA) has a EBIT of ₹39.3 Mil as of Sep. 2023. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Maitreya Medicare.
Is Maitreya Medicare's EBIT too high?
Maitreya Medicare's current EBIT is ₹39.3 Mil. Overall, Maitreya Medicare has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Maitreya Medicare's EBIT compare to HCA and DVA?
Maitreya Medicare's EBIT of ₹39.3 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Maitreya Medicare. Maitreya Medicare's current EBIT is ₹39.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maitreya Medicare stock overvalued right now?
Maitreya Medicare (NSE:MAITREYA) has a current EBIT of ₹39.3 Mil. The current EBIT is ₹39.3 Mil. Maitreya Medicare's overall GF Score™ is 18/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Maitreya Medicare (NSE:MAITREYA), the current EBIT is ₹39.3 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Maitreya Medicare Business Description

Address Nr. Someshwara Char Rasta, Udhana - Magdalla Road, Surat, GJ, IND, 395007
Maitreya Medicare Ltd is Multi Superspeciality hospital. It is a 125 bedded hospital that provides multi-disciplinary integrated healthcare services, with a focus on primary secondary & tertiary care, and also offers a comprehensive range of healthcare services across over 18 specialties and super specialties, including Cardiology, Urology, Oncology, Laparoscopic Surgery, Neurology, Neurosurgery, Spine Surgery, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology & High-Risk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine etc.
18GF Score

Get the complete analysis for NSE:MAITREYA

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹137.85
Price